XML 105 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
GOODWILL AND INTANGIBLE ASSETS
Definite Lived Intangible Assets

(Dollars in thousands)
December 31, 2014
 
December 31, 2013
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Trademarks and patents
$
1,046

 
$
364

 
$
682

 
$
1,075

 
$
303

 
$
772

Technology
33,942

 
15,958

 
17,984

 
37,825

 
13,340

 
24,485

Covenant-not-to-compete
1,016

 
823

 
193

 
1,056

 
628

 
428

Customer relationships
19,123

 
4,406

 
14,717

 
21,280

 
3,235

 
18,045

Total other intangible assets
$
55,127

 
$
21,551

 
$
33,576

 
$
61,236

 
$
17,506

 
$
43,730


In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.
Amortization expense was approximately $6.1 million, $6.0 million and $4.4 million in 2014, 2013 and 2012, respectively. The estimated annual future amortization expense is $5.3 million, $4.9 million, $4.5 million, $3.9 million and $3.4 million in 2015, 2016, 2017, 2018 and 2019, respectively. These amounts could vary based on changes in foreign currency exchange rates.
The weighted average amortization period as of December 31, 2014, by intangible asset class, is presented in the table below:

Intangible Asset Class
 
Weighted Average Amortization Period
Trademarks and patents
 
7.6
Technology
 
4.7
Covenant not-to-compete
 
2.0
Customer relationships
 
7.4
Total other intangible assets
 
5.9

On January 4, 2011 we acquired Curamik, a manufacturer of power electronic substrate products, which contributed $52.4 million of intangible assets and $79.8 million of goodwill. The intangible assets are comprised of trademarks, technology, and customer relationships and include approximately $5.3 million of indefinite-lived intangible assets comprised of trademarks, which are assessed for impairment annually or when changes in circumstances indicate that the carrying values may not be recoverable. The definite-lived intangible assets are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset.
Goodwill
The changes in the carrying amount of goodwill for the period ending December 31, 2014, by reportable segment, were as follows:

(Dollars in thousands)
High Performance Foams
 
Printed Circuit Materials
 
Power Electronics Solutions
 
Other
 
Total
December 31, 2013
$
24,205

 
$

 
$
82,242

 
$
2,224

 
$
108,671

Foreign currency translation adjustment
(640
)
 

 
(9,804
)
 

 
(10,444
)
December 31, 2014
$
23,565

 
$

 
$
72,438

 
$
2,224

 
$
98,227



Annual Impairment Testing

We perform our annual goodwill impairment testing in the fourth quarter of the year. In 2014, we estimated the fair value of our reporting units using an income approach based on the present value of future cash flows. We believe this approach yields the most appropriate evidence of fair value as our reporting units are not easily compared to other corporations involved in similar businesses. We further believe that the assumptions and rates used in our annual impairment test are reasonable, but inherently uncertain. We currently have three reporting units with goodwill and intangible assets - High Performance Foams, Curamik and the Elastomer Components Division (ECD). The HPF, Curamik and ECD reporting units had allocated goodwill of approximately $23.6 million, $72.4 million and $2.2 million, respectively, at December 31, 2014. No impairment charges resulted from these analyses. The excess of fair value over carrying value for these reporting units was 318% for HPF, 85% for Curamik and 77% for ECD. From a sensitivity perspective, if the fair value of these reporting units declined by 10%, the fair value of the HPF reporting unit would exceed its carrying value by approximately 277%, the fair value of the Curamik reporting unit would exceed its carrying value by approximately 65%, and the fair value of the ECD reporting unit would exceed its carrying value by approximately 60%. These valuations are based on a five year discounted cash flow analysis, which utilized a discount rates ranging from 13.0% for HPF and ECD to 15.5% for Curamik and a terminal year growth rate of 3% for all three reporting units.